LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

Phreesia Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

22.6 0.58

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

22.24

Max

22.98

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.6M

654K

Pardavimai

1.3M

117M

Pelno marža

0.558

Darbuotojai

2,082

EBITDA

2.7M

6.8M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+52.31% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-12-08

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-522M

1.4B

Ankstesnė atidarymo kaina

22.02

Ankstesnė uždarymo kaina

22.6

Naujienos nuotaikos

By Acuity

50%

50%

165 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Phreesia Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-05 23:51; UTC

Uždarbis

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

2025-11-05 23:10; UTC

Uždarbis

DBS Third Quarter Net Dips 2.0%

2025-11-05 22:55; UTC

Uždarbis

Arm Holdings 2Q Profit Climbs on Record Demand

2025-11-05 22:23; UTC

Uždarbis

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

2025-11-05 23:52; UTC

Uždarbis

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

2025-11-05 23:49; UTC

Uždarbis

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

2025-11-05 23:49; UTC

Uždarbis

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

2025-11-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

2025-11-05 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

2025-11-05 23:12; UTC

Uždarbis

Nutrien 3Q Adj EPS 97c >NTR.T

2025-11-05 23:11; UTC

Uždarbis

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

2025-11-05 23:10; UTC

Uždarbis

Nutrien 3Q Sales $6.01B >NTR.T

2025-11-05 23:10; UTC

Rinkos pokalbiai
Uždarbis

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

2025-11-05 23:10; UTC

Uždarbis

Nutrien 3Q EPS 96c >NTR.T

2025-11-05 23:04; UTC

Uždarbis

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

2025-11-05 23:03; UTC

Rinkos pokalbiai

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

2025-11-05 22:55; UTC

Rinkos pokalbiai

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

2025-11-05 22:55; UTC

Uždarbis

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

2025-11-05 22:51; UTC

Uždarbis

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

2025-11-05 22:50; UTC

Uždarbis

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

2025-11-05 22:44; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

2025-11-05 22:43; UTC

Rinkos pokalbiai
Uždarbis

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

2025-11-05 22:36; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-05 22:36; UTC

Rinkos pokalbiai

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

2025-11-05 22:20; UTC

Rinkos pokalbiai

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

2025-11-05 22:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

2025-11-05 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

2025-11-05 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Responds to Delaware Chancery Court Ruling

2025-11-05 22:01; UTC

Uždarbis

Great-West Lifeco 3Q Net C$1.16B >GWO.T

2025-11-05 22:01; UTC

Uždarbis

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Akcijų palyginimas

Kainos pokytis

Phreesia Inc Prognozė

Kainos tikslas

By TipRanks

52.31% į viršų

12 mėnesių prognozė

Vidutinis 34.33 USD  52.31%

Aukščiausias 38 USD

Žemiausias 32 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phreesia Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

11 ratings

11

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

25.23 / 25.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

165 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat